S100 Family: 3.50.50.60.8.1.1.1

Representative domain: 1gteA03

Classification Lineage (3.50.50.60.8.1.1.1)

CATH Code	Level Description	Links
3	Alpha Beta
3.50	3-Layer(bba) Sandwich
3.50.50	FAD/NAD(P)-binding domain
3.50.50.60		Gene3D
3.50.50.60.8
3.50.50.60.8.1
3.50.50.60.8.1.1
3.50.50.60.8.1.1.1

Summary of Non-Redundant Representatives


-	-	-	-	-	-	-	-	20

Non-Redundant Representatives (20)
Functional Families
Help

What is a Non-Redundant Representative?

CATH is a tree-like organisation of nodes that begins with the class node (i.e. the first branch-point of the tree) and ends with the domain nodes (i.e. the leaves of the tree). Each node below the class have a parent that they belong to, e.g. the parent of the H level (Homologous superfamily) is the T (Topology). Additionally, each node above the domains have child nodes that belong to them, e.g. the child nodes of a given H (Homologous superfamily) level are the S35 families (domains clustered at > 35% sequence identity).

S100 Count Entries in S100 Family 3.50.50.60.8.1.1.1 (20)

CATH code	Domain ID	Keywords
3.50.50.60.8.1.1.1.1	1gteA03	beta-Alanine metabolism, Metabolic pathways, FMN binding, protein homodimerization activity, NADP or NADPH binding, Pyrimidine metabolism, dihydropyrimidine dehydrogenase (NADP+) activity, flavin adenine dinucleotide binding, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Sus scrofa, Pantothenate and CoA biosynthesis, Dihydropyrimidine dehydrogenase [NADP+], Dihydropyrimidine dehydrogenase (NADP(+))., Drug metabolism - other enzymes
3.50.50.60.8.1.1.1.2	1gteB03	dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Sus scrofa, flavin adenine dinucleotide binding, dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism, Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase [NADP+], Dihydropyrimidine dehydrogenase (NADP(+))., Pantothenate and CoA biosynthesis, beta-Alanine metabolism, NADP or NADPH binding, protein homodimerization activity, Metabolic pathways, FMN binding
3.50.50.60.8.1.1.1.3	1gteC03	beta-Alanine metabolism, Metabolic pathways, FMN binding, protein homodimerization activity, NADP or NADPH binding, Pyrimidine metabolism, dihydropyrimidine dehydrogenase (NADP+) activity, flavin adenine dinucleotide binding, Sus scrofa, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Pantothenate and CoA biosynthesis, Dihydropyrimidine dehydrogenase (NADP(+))., Dihydropyrimidine dehydrogenase [NADP+], Drug metabolism - other enzymes
3.50.50.60.8.1.1.1.4	1gteD03	beta-Alanine metabolism, protein homodimerization activity, Metabolic pathways, FMN binding, NADP or NADPH binding, flavin adenine dinucleotide binding, dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism, Sus scrofa, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Pantothenate and CoA biosynthesis, Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase (NADP(+))., Dihydropyrimidine dehydrogenase [NADP+]
3.50.50.60.8.1.1.1.5	1h7wA03	Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase [NADP+], Dihydropyrimidine dehydrogenase (NADP(+))., Pantothenate and CoA biosynthesis, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Sus scrofa, flavin adenine dinucleotide binding, dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism, NADP or NADPH binding, protein homodimerization activity, Metabolic pathways, FMN binding, beta-Alanine metabolism
3.50.50.60.8.1.1.1.6	1h7wB03	Pantothenate and CoA biosynthesis, Dihydropyrimidine dehydrogenase (NADP(+))., Dihydropyrimidine dehydrogenase [NADP+], Drug metabolism - other enzymes, dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism, flavin adenine dinucleotide binding, Sus scrofa, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], protein homodimerization activity, Metabolic pathways, FMN binding, NADP or NADPH binding, beta-Alanine metabolism
3.50.50.60.8.1.1.1.7	1h7wC03	NADP or NADPH binding, protein homodimerization activity, Metabolic pathways, FMN binding, beta-Alanine metabolism, Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase [NADP+], Dihydropyrimidine dehydrogenase (NADP(+))., Pantothenate and CoA biosynthesis, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Sus scrofa, flavin adenine dinucleotide binding, dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism
3.50.50.60.8.1.1.1.8	1h7wD03	protein homodimerization activity, Metabolic pathways, FMN binding, NADP or NADPH binding, beta-Alanine metabolism, Pantothenate and CoA biosynthesis, Dihydropyrimidine dehydrogenase (NADP(+))., Dihydropyrimidine dehydrogenase [NADP+], Drug metabolism - other enzymes, dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism, flavin adenine dinucleotide binding, Sus scrofa, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2]
3.50.50.60.8.1.1.1.9	1h7xA03	flavin adenine dinucleotide binding, Pyrimidine metabolism, dihydropyrimidine dehydrogenase (NADP+) activity, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Sus scrofa, Pantothenate and CoA biosynthesis, Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase [NADP+], Dihydropyrimidine dehydrogenase (NADP(+))., beta-Alanine metabolism, Metabolic pathways, FMN binding, protein homodimerization activity, NADP or NADPH binding
3.50.50.60.8.1.1.1.10	1h7xB03	dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Sus scrofa, flavin adenine dinucleotide binding, dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism, Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase [NADP+], Dihydropyrimidine dehydrogenase (NADP(+))., Pantothenate and CoA biosynthesis, beta-Alanine metabolism, NADP or NADPH binding, protein homodimerization activity, Metabolic pathways, FMN binding
3.50.50.60.8.1.1.1.11	1h7xC03	Pantothenate and CoA biosynthesis, Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase [NADP+], Dihydropyrimidine dehydrogenase (NADP(+))., flavin adenine dinucleotide binding, Pyrimidine metabolism, dihydropyrimidine dehydrogenase (NADP+) activity, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Sus scrofa, Metabolic pathways, FMN binding, protein homodimerization activity, NADP or NADPH binding, beta-Alanine metabolism
3.50.50.60.8.1.1.1.12	1h7xD03	protein homodimerization activity, Metabolic pathways, FMN binding, NADP or NADPH binding, beta-Alanine metabolism, Pantothenate and CoA biosynthesis, Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase [NADP+], Dihydropyrimidine dehydrogenase (NADP(+))., flavin adenine dinucleotide binding, dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Sus scrofa
3.50.50.60.8.1.1.1.13	1gthA03	Sus scrofa, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism, flavin adenine dinucleotide binding, Dihydropyrimidine dehydrogenase (NADP(+))., Dihydropyrimidine dehydrogenase [NADP+], Drug metabolism - other enzymes, Pantothenate and CoA biosynthesis, beta-Alanine metabolism, NADP or NADPH binding, protein homodimerization activity, Metabolic pathways, FMN binding
3.50.50.60.8.1.1.1.14	1gthB03	NADP or NADPH binding, protein homodimerization activity, Metabolic pathways, FMN binding, beta-Alanine metabolism, Dihydropyrimidine dehydrogenase [NADP+], Dihydropyrimidine dehydrogenase (NADP(+))., Drug metabolism - other enzymes, Pantothenate and CoA biosynthesis, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Sus scrofa, dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism, flavin adenine dinucleotide binding
3.50.50.60.8.1.1.1.15	1gthC03	Metabolic pathways, FMN binding, protein homodimerization activity, NADP or NADPH binding, beta-Alanine metabolism, Pantothenate and CoA biosynthesis, Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase (NADP(+))., Dihydropyrimidine dehydrogenase [NADP+], flavin adenine dinucleotide binding, Pyrimidine metabolism, dihydropyrimidine dehydrogenase (NADP+) activity, Sus scrofa, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2]
3.50.50.60.8.1.1.1.16	1gthD03	protein homodimerization activity, Metabolic pathways, FMN binding, NADP or NADPH binding, beta-Alanine metabolism, Pantothenate and CoA biosynthesis, Dihydropyrimidine dehydrogenase (NADP(+))., Dihydropyrimidine dehydrogenase [NADP+], Drug metabolism - other enzymes, dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism, flavin adenine dinucleotide binding, Sus scrofa, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2]
3.50.50.60.8.1.1.1.17	1gt8A03	Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase [NADP+], Dihydropyrimidine dehydrogenase (NADP(+))., Pantothenate and CoA biosynthesis, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Sus scrofa, flavin adenine dinucleotide binding, dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism, NADP or NADPH binding, protein homodimerization activity, Metabolic pathways, FMN binding, beta-Alanine metabolism
3.50.50.60.8.1.1.1.18	1gt8B03	beta-Alanine metabolism, NADP or NADPH binding, Metabolic pathways, FMN binding, protein homodimerization activity, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], Sus scrofa, flavin adenine dinucleotide binding, Pyrimidine metabolism, dihydropyrimidine dehydrogenase (NADP+) activity, Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase [NADP+], Dihydropyrimidine dehydrogenase (NADP(+))., Pantothenate and CoA biosynthesis
3.50.50.60.8.1.1.1.19	1gt8C03	NADP or NADPH binding, protein homodimerization activity, Metabolic pathways, FMN binding, beta-Alanine metabolism, Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase (NADP(+))., Dihydropyrimidine dehydrogenase [NADP+], Pantothenate and CoA biosynthesis, Sus scrofa, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], flavin adenine dinucleotide binding, dihydropyrimidine dehydrogenase (NADP+) activity, Pyrimidine metabolism
3.50.50.60.8.1.1.1.20	1gt8D03	beta-Alanine metabolism, NADP or NADPH binding, Metabolic pathways, FMN binding, protein homodimerization activity, Sus scrofa, dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2], flavin adenine dinucleotide binding, Pyrimidine metabolism, dihydropyrimidine dehydrogenase (NADP+) activity, Drug metabolism - other enzymes, Dihydropyrimidine dehydrogenase (NADP(+))., Dihydropyrimidine dehydrogenase [NADP+], Pantothenate and CoA biosynthesis

The information on Functional Families (FunFams) is currently being updated and will be released by the end of March 2012. The pages will include the following features:

Multiple alignments for each functional family
Representative structure for each functional with known catalytic and interface residues highlighted, along with conserved residues predicted by scorecons
Detailed functional information on diversity and conservation within Functional families
Multi-domain architectures

In the meantime, please find a summary of information on the FunFams and protein networks within this superfamily on the Gene3D pages:

http://gene3d.biochem.ucl.ac.uk/superfamily/?accession=3.50.50.60.8.1.1.1

What is a Non-Redundant Representative?

Why can't I have a multiple structural alignment of the whole superfamily?

The simple answer is that some of the larger superfamilies in CATH comprise relatives which are very structurally diverse, having different secondary structure embellishments. Attempting to provide a global alignment of all domains in the superfamily would result in poor quality alignments. As a result, structural alignments in CATH are generated by first clustering together the structures that have at least some recognisable structural similarity using a normalised RMSD score (SIMAX = RMSDxNumber of residues in the largest domain/number of aligned residues) less than a given cutoff.

What is an Close Structural Cluster?

A Close Structural Cluster describes a cluster of two or more CATH domains that have been grouped together due to their close structural similarity (SIMAX score < 5Å where SIMAX = RMSD x Number of residues in the larger domain/number of aligned residues).

What is a Distant Structural Cluster?

A Distant Structural Cluster describes a cluster of two or CATH domains that have been grouped together with a more relaxed structural similarity threshold to investigate more distant evolutionary similarities (SIMAX score < 5Å where SIMAX = RMSD x Number of residues in the larger domain/number of aligned residues).

What is a Structural Neighbour?

The term "structural neighbour" is used here to describe two CATH domains that share a degree of structural similarity. The SSAP algorithm is used to calculate this similarity and works by generating a structure-based pairwise alignment of the two domains then scoring this alignment using a RMSD score which has been normalised by the length of the larger domain divided by the number of aligned residues (SIMAX).

S100 Family: 3.50.50.60.8.1.1.1

Classification Lineage (3.50.50.60.8.1.1.1)

Summary of Non-Redundant Representatives

What is a Non-Redundant Representative?

S100 Count Entries in S100 Family 3.50.50.60.8.1.1.1 (20)

What is a Non-Redundant Representative?

Why can't I have a multiple structural alignment of the whole superfamily?

What is an Close Structural Cluster?

What is a Distant Structural Cluster?

What is a Structural Neighbour?

CATH Shortcuts